Why are so many people with PD receiving less than the best treatment?
The complexity associated with decision making for difficult diseases that continuously change like PD is a challenge to learn, recall, and building parameters associated with the risk and benefits of trial participation versus approved treatment options prove to be very difficult tasks for many providers. As a result, the patient does not always learn about or participate in trials that may advance medicine and provide direct benefit. A very similar problem is associated with approved medications at large because the number of available options continues to increase as the time doctors are allowed to spend with each patient dwindles as providers are regulated by employers to limit visit time and maximize billable events.
New and less established medications are often appropriate for patients but not prescribed and patients are unaware that the treatment plan they receive is sub-par. Hundreds of thousands of Parkinson’s patients across the US could live a higher quality of life if they were on an optimal treatment plan.